*AI-Enabled Reviewer Tool for MDSAP Audit Report Reviews
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $700,000 to $1,500,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring an AI-enabled reviewer tool to analyze MDSAP audit report outcomes, surface potential risk indicators, and prioritize reports for manual review. The tool will support more efficient allocation of reviewer resources by directing attention to higher-risk submissions first while preserving human oversight in final determinations. Solicitation release is estimated for July 1, 2026, with award anticipated January 1, 2027.
The estimated award value ranges from $700,000 to $1.5 million. Interested vendors should direct inquiries to cdhracquisitions@fda.hhs.gov.
Forecast text
An AI-powered tool is proposed to analyze MDSAP audit report outcomes, surface potential risk indicators, and prioritize reports for manual review. This would support more efficient allocation of reviewer resources by directing attention to higher-risk submissions first, while preserving human oversight in final determinations.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast